<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE html><html xmlns="http://www.w3.org/1999/xhtml" xmlns:art="http://www.rsc.org/schema/rscart38" xmlns:epub="http://www.idpf.org/2007/ops" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rsc="urn:rsc.org" xml:lang="en" lang="en"><head><!--Google Tag Manager--><script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&amp;l='+l:'';j.async=true;j.src=
'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-56FZ7G');</script><!--End Google Tag Manager--><title>Controlled synthesis of brightly fluorescent CH 3 NH 3 PbBr 3 perovskite nanocrystals employing Pb(C 17 H 33 COO) 2 as the sole lead source   - RSC Advances (RSC Publishing) DOI:10.1039/C7RA11832E</title><link rel="canonical" href="https://pubs.rsc.org/en/content/articlehtml/2018/ra/c7ra11832e"/><meta http-equiv="content-type" content="application/xhtml+xml; charset=utf-8"/><script type="text/javascript">window.NREUM||(NREUM={});NREUM.info = {"beacon":"bam.nr-data.net","errorBeacon":"bam.nr-data.net","licenseKey":"NRJS-aaa897feae8feeca979","applicationID":"1313546638","transactionName":"M1wANxQFCEcDVU0PWgoWLzUlSyVbDEJcCEEnVgwXFAsKWAdEFgdHEFABDwMMElkO","queueTime":0,"applicationTime":65,"agent":"","atts":""}</script><script type="text/javascript">(window.NREUM||(NREUM={})).init={privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]},distributed_tracing:{enabled:true}};(window.NREUM||(NREUM={})).loader_config={agentID:"1386013924",accountID:"2851366",trustKey:"1029994",xpid:"Vg4CUFVVDhABV1BRAgUBUFcJ",licenseKey:"NRJS-aaa897feae8feeca979",applicationID:"1313546638"};window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({1:[function(t,e,n){function r(t){try{s.console&&console.log(t)}catch(e){}}var o,i=t("ee"),a=t(31),s={};try{o=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(s.console=!0,o.indexOf("dev")!==-1&&(s.dev=!0),o.indexOf("nr_dev")!==-1&&(s.nrDev=!0))}catch(c){}s.nrDev&&i.on("internal-error",function(t){r(t.stack)}),s.dev&&i.on("fn-err",function(t,e,n){r(n.stack)}),s.dev&&(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(s,function(t,e){return t}).join(", ")))},{}],2:[function(t,e,n){function r(t,e,n,r,s){try{l?l-=1:o(s||new UncaughtException(t,e,n),!0)}catch(f){try{i("ierr",[f,c.now(),!0])}catch(d){}}return"function"==typeof u&&u.apply(this,a(arguments))}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function o(t,e){var n=e?null:c.now();i("err",[t,n])}var i=t("handle"),a=t(32),s=t("ee"),c=t("loader"),f=t("gos"),u=window.onerror,d=!1,p="nr@seenError";if(!c.disabled){var l=0;c.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(h){"stack"in h&&(t(14),t(13),"addEventListener"in window&&t(7),c.xhrWrappable&&t(15),d=!0)}s.on("fn-start",function(t,e,n){d&&(l+=1)}),s.on("fn-err",function(t,e,n){d&&!n[p]&&(f(n,p,function(){return!0}),this.thrown=!0,o(n))}),s.on("fn-end",function(){d&&!this.thrown&&l>0&&(l-=1)}),s.on("internal-error",function(t){i("ierr",[t,c.now(),!0])})}},{}],3:[function(t,e,n){var r=t("loader");r.disabled||(r.features.ins=!0)},{}],4:[function(t,e,n){function r(){U++,L=g.hash,this[u]=y.now()}function o(){U--,g.hash!==L&&i(0,!0);var t=y.now();this[h]=~~this[h]+t-this[u],this[d]=t}function i(t,e){E.emit("newURL",[""+g,e])}function a(t,e){t.on(e,function(){this[e]=y.now()})}var s="-start",c="-end",f="-body",u="fn"+s,d="fn"+c,p="cb"+s,l="cb"+c,h="jsTime",m="fetch",v="addEventListener",w=window,g=w.location,y=t("loader");if(w[v]&&y.xhrWrappable&&!y.disabled){var x=t(11),b=t(12),E=t(9),R=t(7),O=t(14),T=t(8),S=t(15),P=t(10),M=t("ee"),C=M.get("tracer"),N=t(23);t(17),y.features.spa=!0;var L,U=0;M.on(u,r),b.on(p,r),P.on(p,r),M.on(d,o),b.on(l,o),P.on(l,o),M.buffer([u,d,"xhr-resolved"]),R.buffer([u]),O.buffer(["setTimeout"+c,"clearTimeout"+s,u]),S.buffer([u,"new-xhr","send-xhr"+s]),T.buffer([m+s,m+"-done",m+f+s,m+f+c]),E.buffer(["newURL"]),x.buffer([u]),b.buffer(["propagate",p,l,"executor-err","resolve"+s]),C.buffer([u,"no-"+u]),P.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"]),a(T,m+s),a(T,m+"-done"),a(P,"new-jsonp"),a(P,"jsonp-end"),a(P,"cb-start"),E.on("pushState-end",i),E.on("replaceState-end",i),w[v]("hashchange",i,N(!0)),w[v]("load",i,N(!0)),w[v]("popstate",function(){i(0,U>1)},N(!0))}},{}],5:[function(t,e,n){function r(){var t=new PerformanceObserver(function(t,e){var n=t.getEntries();s(v,[n])});try{t.observe({entryTypes:["resource"]})}catch(e){}}function o(t){if(s(v,[window.performance.getEntriesByType(w)]),window.performance["c"+p])try{window.performance[h](m,o,!1)}catch(t){}else try{window.performance[h]("webkit"+m,o,!1)}catch(t){}}function i(t){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var a=t("ee"),s=t("handle"),c=t(14),f=t(13),u=t(6),d=t(23),p="learResourceTimings",l="addEventListener",h="removeEventListener",m="resourcetimingbufferfull",v="bstResource",w="resource",g="-start",y="-end",x="fn"+g,b="fn"+y,E="bstTimer",R="pushState",O=t("loader");if(!O.disabled){O.features.stn=!0,t(9),"addEventListener"in window&&t(7);var T=NREUM.o.EV;a.on(x,function(t,e){var n=t[0];n instanceof T&&(this.bstStart=O.now())}),a.on(b,function(t,e){var n=t[0];n instanceof T&&s("bst",[n,e,this.bstStart,O.now()])}),c.on(x,function(t,e,n){this.bstStart=O.now(),this.bstType=n}),c.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),this.bstType])}),f.on(x,function(){this.bstStart=O.now()}),f.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),"requestAnimationFrame"])}),a.on(R+g,function(t){this.time=O.now(),this.startPath=location.pathname+location.hash}),a.on(R+y,function(t){s("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),u()?(s(v,[window.performance.getEntriesByType("resource")]),r()):l in window.performance&&(window.performance["c"+p]?window.performance[l](m,o,d(!1)):window.performance[l]("webkit"+m,o,d(!1))),document[l]("scroll",i,d(!1)),document[l]("keypress",i,d(!1)),document[l]("click",i,d(!1))}}},{}],6:[function(t,e,n){e.exports=function(){return"PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver}},{}],7:[function(t,e,n){function r(t){for(var e=t;e&&!e.hasOwnProperty(u);)e=Object.getPrototypeOf(e);e&&o(e)}function o(t){s.inPlace(t,[u,d],"-",i)}function i(t,e){return t[1]}var a=t("ee").get("events"),s=t("wrap-function")(a,!0),c=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";e.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1];if(null!==n&&("function"==typeof n||"object"==typeof n)){var r=c(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?s(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],8:[function(t,e,n){function r(t,e,n){var r=t[e];"function"==typeof r&&(t[e]=function(){var t=i(arguments),e={};o.emit(n+"before-start",[t],e);var a;e[m]&&e[m].dt&&(a=e[m].dt);var s=r.apply(this,t);return o.emit(n+"start",[t,a],s),s.then(function(t){return o.emit(n+"end",[null,t],s),t},function(t){throw o.emit(n+"end",[t],s),t})})}var o=t("ee").get("fetch"),i=t(32),a=t(31);e.exports=o;var s=window,c="fetch-",f=c+"body-",u=["arrayBuffer","blob","json","text","formData"],d=s.Request,p=s.Response,l=s.fetch,h="prototype",m="nr@context";d&&p&&l&&(a(u,function(t,e){r(d[h],e,f),r(p[h],e,f)}),r(s,"fetch",c),o.on(c+"end",function(t,e){var n=this;if(e){var r=e.headers.get("content-length");null!==r&&(n.rxSize=r),o.emit(c+"done",[null,e],n)}else o.emit(c+"done",[t],n)}))},{}],9:[function(t,e,n){var r=t("ee").get("history"),o=t("wrap-function")(r);e.exports=r;var i=window.history&&window.history.constructor&&window.history.constructor.prototype,a=window.history;i&&i.pushState&&i.replaceState&&(a=i),o.inPlace(a,["pushState","replaceState"],"-")},{}],10:[function(t,e,n){function r(t){function e(){f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}function n(){f.emit("jsonp-error",[],l),f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}var r=t&&"string"==typeof t.nodeName&&"script"===t.nodeName.toLowerCase();if(r){var o="function"==typeof t.addEventListener;if(o){var a=i(t.src);if(a){var d=s(a),p="function"==typeof d.parent[d.key];if(p){var l={};u.inPlace(d.parent,[d.key],"cb-",l),t.addEventListener("load",e,c(!1)),t.addEventListener("error",n,c(!1)),f.emit("new-jsonp",[t.src],l)}}}}}function o(){return"addEventListener"in window}function i(t){var e=t.match(d);return e?e[1]:null}function a(t,e){var n=t.match(l),r=n[1],o=n[3];return o?a(o,e[r]):e[r]}function s(t){var e=t.match(p);return e&&e.length>=3?{key:e[2],parent:a(e[1],window)}:{key:t,parent:window}}var c=t(23),f=t("ee").get("jsonp"),u=t("wrap-function")(f);if(e.exports=f,o()){var d=/[?&](?:callback|cb)=([^&#]+)/,p=/(.*)\.([^.]+)/,l=/^(\w+)(\.|$)(.*)$/,h=["appendChild","insertBefore","replaceChild"];Node&&Node.prototype&&Node.prototype.appendChild?u.inPlace(Node.prototype,h,"dom-"):(u.inPlace(HTMLElement.prototype,h,"dom-"),u.inPlace(HTMLHeadElement.prototype,h,"dom-"),u.inPlace(HTMLBodyElement.prototype,h,"dom-")),f.on("dom-start",function(t){r(t[0])})}},{}],11:[function(t,e,n){var r=t("ee").get("mutation"),o=t("wrap-function")(r),i=NREUM.o.MO;e.exports=r,i&&(window.MutationObserver=function(t){return this instanceof i?new i(o(t,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype)},{}],12:[function(t,e,n){function r(t){var e=i.context(),n=s(t,"executor-",e,null,!1),r=new f(n);return i.context(r).getCtx=function(){return e},r}var o=t("wrap-function"),i=t("ee").get("promise"),a=t("ee").getOrSetContext,s=o(i),c=t(31),f=NREUM.o.PR;e.exports=i,f&&(window.Promise=r,["all","race"].forEach(function(t){var e=f[t];f[t]=function(n){function r(t){return function(){i.emit("propagate",[null,!o],a,!1,!1),o=o||!t}}var o=!1;c(n,function(e,n){Promise.resolve(n).then(r("all"===t),r(!1))});var a=e.apply(f,arguments),s=f.resolve(a);return s}}),["resolve","reject"].forEach(function(t){var e=f[t];f[t]=function(t){var n=e.apply(f,arguments);return t!==n&&i.emit("propagate",[t,!0],n,!1,!1),n}}),f.prototype["catch"]=function(t){return this.then(null,t)},f.prototype=Object.create(f.prototype,{constructor:{value:r}}),c(Object.getOwnPropertyNames(f),function(t,e){try{r[e]=f[e]}catch(n){}}),o.wrapInPlace(f.prototype,"then",function(t){return function(){var e=this,n=o.argsToArray.apply(this,arguments),r=a(e);r.promise=e,n[0]=s(n[0],"cb-",r,null,!1),n[1]=s(n[1],"cb-",r,null,!1);var c=t.apply(this,n);return r.nextPromise=c,i.emit("propagate",[e,!0],c,!1,!1),c}}),i.on("executor-start",function(t){t[0]=s(t[0],"resolve-",this,null,!1),t[1]=s(t[1],"resolve-",this,null,!1)}),i.on("executor-err",function(t,e,n){t[1](n)}),i.on("cb-end",function(t,e,n){i.emit("propagate",[n,!0],this.nextPromise,!1,!1)}),i.on("propagate",function(t,e,n){this.getCtx&&!e||(this.getCtx=function(){if(t instanceof Promise)var e=i.context(t);return e&&e.getCtx?e.getCtx():this})}),r.toString=function(){return""+f})},{}],13:[function(t,e,n){var r=t("ee").get("raf"),o=t("wrap-function")(r),i="equestAnimationFrame";e.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],14:[function(t,e,n){function r(t,e,n){t[0]=a(t[0],"fn-",null,n)}function o(t,e,n){this.method=n,this.timerDuration=isNaN(t[1])?0:+t[1],t[0]=a(t[0],"fn-",this,n)}var i=t("ee").get("timer"),a=t("wrap-function")(i),s="setTimeout",c="setInterval",f="clearTimeout",u="-start",d="-";e.exports=i,a.inPlace(window,[s,"setImmediate"],s+d),a.inPlace(window,[c],c+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(c+u,r),i.on(s+u,o)},{}],15:[function(t,e,n){function r(t,e){d.inPlace(e,["onreadystatechange"],"fn-",s)}function o(){var t=this,e=u.context(t);t.readyState>3&&!e.resolved&&(e.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,y,"fn-",s)}function i(t){x.push(t),m&&(E?E.then(a):w?w(a):(R=-R,O.data=R))}function a(){for(var t=0;t<x.length;t++)r([],x[t]);x.length&&(x=[])}function s(t,e){return e}function c(t,e){for(var n in t)e[n]=t[n];return e}t(7);var f=t("ee"),u=f.get("xhr"),d=t("wrap-function")(u),p=t(23),l=NREUM.o,h=l.XHR,m=l.MO,v=l.PR,w=l.SI,g="readystatechange",y=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],x=[];e.exports=u;var b=window.XMLHttpRequest=function(t){var e=new h(t);try{u.emit("new-xhr",[e],e),e.addEventListener(g,o,p(!1))}catch(n){try{u.emit("internal-error",[n])}catch(r){}}return e};if(c(h,b),b.prototype=h.prototype,d.inPlace(b.prototype,["open","send"],"-xhr-",s),u.on("send-xhr-start",function(t,e){r(t,e),i(e)}),u.on("open-xhr-start",r),m){var E=v&&v.resolve();if(!w&&!v){var R=1,O=document.createTextNode(R);new m(a).observe(O,{characterData:!0})}}else f.on("fn-end",function(t){t[0]&&t[0].type===g||a()})},{}],16:[function(t,e,n){function r(t){if(!s(t))return null;var e=window.NREUM;if(!e.loader_config)return null;var n=(e.loader_config.accountID||"").toString()||null,r=(e.loader_config.agentID||"").toString()||null,f=(e.loader_config.trustKey||"").toString()||null;if(!n||!r)return null;var h=l.generateSpanId(),m=l.generateTraceId(),v=Date.now(),w={spanId:h,traceId:m,timestamp:v};return(t.sameOrigin||c(t)&&p())&&(w.traceContextParentHeader=o(h,m),w.traceContextStateHeader=i(h,v,n,r,f)),(t.sameOrigin&&!u()||!t.sameOrigin&&c(t)&&d())&&(w.newrelicHeader=a(h,m,v,n,r,f)),w}function o(t,e){return"00-"+e+"-"+t+"-01"}function i(t,e,n,r,o){var i=0,a="",s=1,c="",f="";return o+"@nr="+i+"-"+s+"-"+n+"-"+r+"-"+t+"-"+a+"-"+c+"-"+f+"-"+e}function a(t,e,n,r,o,i){var a="btoa"in window&&"function"==typeof window.btoa;if(!a)return null;var s={v:[0,1],d:{ty:"Browser",ac:r,ap:o,id:t,tr:e,ti:n}};return i&&r!==i&&(s.d.tk=i),btoa(JSON.stringify(s))}function s(t){return f()&&c(t)}function c(t){var e=!1,n={};if("init"in NREUM&&"distributed_tracing"in NREUM.init&&(n=NREUM.init.distributed_tracing),t.sameOrigin)e=!0;else if(n.allowed_origins instanceof Array)for(var r=0;r<n.allowed_origins.length;r++){var o=h(n.allowed_origins[r]);if(t.hostname===o.hostname&&t.protocol===o.protocol&&t.port===o.port){e=!0;break}}return e}function f(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.enabled}function u(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.exclude_newrelic_header}function d(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&NREUM.init.distributed_tracing.cors_use_newrelic_header!==!1}function p(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.cors_use_tracecontext_headers}var l=t(28),h=t(18);e.exports={generateTracePayload:r,shouldGenerateTrace:s}},{}],17:[function(t,e,n){function r(t){var e=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r<p;r++)t.removeEventListener(d[r],this.listener,!1);return e.protocol&&"data"===e.protocol?void g("Ajax/DataUrl/Excluded"):void(e.aborted||(n.duration=a.now()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==e.status&&(e.status=0):i(this,t),n.cbTime=this.cbTime,s("xhr",[e,n,this.startTime,this.endTime,"xhr"],this)))}}function o(t,e){var n=c(e),r=t.params;r.hostname=n.hostname,r.port=n.port,r.protocol=n.protocol,r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.parsedOrigin=n,t.sameOrigin=n.sameOrigin}function i(t,e){t.params.status=e.status;var n=v(e,t.lastSize);if(n&&(t.metrics.rxSize=n),t.sameOrigin){var r=e.getResponseHeader("X-NewRelic-App-Data");r&&(t.params.cat=r.split(", ").pop())}t.loadCaptureCalled=!0}var a=t("loader");if(a.xhrWrappable&&!a.disabled){var s=t("handle"),c=t(18),f=t(16).generateTracePayload,u=t("ee"),d=["load","error","abort","timeout"],p=d.length,l=t("id"),h=t(24),m=t(22),v=t(19),w=t(23),g=t(25).recordSupportability,y=NREUM.o.REQ,x=window.XMLHttpRequest;a.features.xhr=!0,t(15),t(8),u.on("new-xhr",function(t){var e=this;e.totalCbs=0,e.called=0,e.cbTime=0,e.end=r,e.ended=!1,e.xhrGuids={},e.lastSize=null,e.loadCaptureCalled=!1,e.params=this.params||{},e.metrics=this.metrics||{},t.addEventListener("load",function(n){i(e,t)},w(!1)),h&&(h>34||h<10)||t.addEventListener("progress",function(t){e.lastSize=t.loaded},w(!1))}),u.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),u.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid);var n=f(this.parsedOrigin);if(n){var r=!1;n.newrelicHeader&&(e.setRequestHeader("newrelic",n.newrelicHeader),r=!0),n.traceContextParentHeader&&(e.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&e.setRequestHeader("tracestate",n.traceContextStateHeader),r=!0),r&&(this.dt=n)}}),u.on("send-xhr-start",function(t,e){var n=this.metrics,r=t[0],o=this;if(n&&r){var i=m(r);i&&(n.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"!==t.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof e.onload))&&o.end(e)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}};for(var s=0;s<p;s++)e.addEventListener(d[s],this.listener,w(!1))}),u.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),u.on("xhr-load-added",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),u.on("xhr-load-removed",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),u.on("xhr-resolved",function(){this.endTime=a.now()}),u.on("addEventListener-end",function(t,e){e instanceof x&&"load"===t[0]&&u.emit("xhr-load-added",[t[1],t[2]],e)}),u.on("removeEventListener-end",function(t,e){e instanceof x&&"load"===t[0]&&u.emit("xhr-load-removed",[t[1],t[2]],e)}),u.on("fn-start",function(t,e,n){e instanceof x&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),u.on("fn-end",function(t,e){this.xhrCbStart&&u.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,e],e)}),u.on("fetch-before-start",function(t){function e(t,e){var n=!1;return e.newrelicHeader&&(t.set("newrelic",e.newrelicHeader),n=!0),e.traceContextParentHeader&&(t.set("traceparent",e.traceContextParentHeader),e.traceContextStateHeader&&t.set("tracestate",e.traceContextStateHeader),n=!0),n}var n,r=t[1]||{};"string"==typeof t[0]?n=t[0]:t[0]&&t[0].url?n=t[0].url:window.URL&&t[0]&&t[0]instanceof URL&&(n=t[0].href),n&&(this.parsedOrigin=c(n),this.sameOrigin=this.parsedOrigin.sameOrigin);var o=f(this.parsedOrigin);if(o&&(o.newrelicHeader||o.traceContextParentHeader))if("string"==typeof t[0]||window.URL&&t[0]&&t[0]instanceof URL){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),e(i.headers,o)&&(this.dt=o),t.length>1?t[1]=i:t.push(i)}else t[0]&&t[0].headers&&e(t[0].headers,o)&&(this.dt=o)}),u.on("fetch-start",function(t,e){this.params={},this.metrics={},this.startTime=a.now(),this.dt=e,t.length>=1&&(this.target=t[0]),t.length>=2&&(this.opts=t[1]);var n,r=this.opts||{},i=this.target;if("string"==typeof i?n=i:"object"==typeof i&&i instanceof y?n=i.url:window.URL&&"object"==typeof i&&i instanceof URL&&(n=i.href),o(this,n),"data"!==this.params.protocol){var s=(""+(i&&i instanceof y&&i.method||r.method||"GET")).toUpperCase();this.params.method=s,this.txSize=m(r.body)||0}}),u.on("fetch-done",function(t,e){if(this.endTime=a.now(),this.params||(this.params={}),"data"===this.params.protocol)return void g("Ajax/DataUrl/Excluded");this.params.status=e?e.status:0;var n;"string"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var r={txSize:this.txSize,rxSize:n,duration:a.now()-this.startTime};s("xhr",[this.params,r,this.startTime,this.endTime,"fetch"],this)})}},{}],18:[function(t,e,n){var r={};e.exports=function(t){if(t in r)return r[t];if(0===(t||"").indexOf("data:"))return{protocol:"data"};var e=document.createElement("a"),n=window.location,o={};e.href=t,o.port=e.port;var i=e.href.split("://");!o.port&&i[1]&&(o.port=i[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===i[0]?"443":"80"),o.hostname=e.hostname||n.hostname,o.pathname=e.pathname,o.protocol=i[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var a=!e.protocol||":"===e.protocol||e.protocol===n.protocol,s=e.hostname===document.domain&&e.port===n.port;return o.sameOrigin=a&&(!e.hostname||s),"/"===o.pathname&&(r[t]=o),o}},{}],19:[function(t,e,n){function r(t,e){var n=t.responseType;return"json"===n&&null!==e?e:"arraybuffer"===n||"blob"===n||"json"===n?o(t.response):"text"===n||""===n||void 0===n?o(t.responseText):void 0}var o=t(22);e.exports=r},{}],20:[function(t,e,n){function r(){}function o(t,e,n,r){return function(){return u.recordSupportability("API/"+e+"/called"),i(t+e,[f.now()].concat(s(arguments)),n?null:this,r),n?void 0:this}}var i=t("handle"),a=t(31),s=t(32),c=t("ee").get("tracer"),f=t("loader"),u=t(25),d=NREUM;"undefined"==typeof window.newrelic&&(newrelic=d);var p=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],l="api-",h=l+"ixn-";a(p,function(t,e){d[e]=o(l,e,!0,"api")}),d.addPageAction=o(l,"addPageAction",!0),d.setCurrentRouteName=o(l,"routeName",!0),e.exports=newrelic,d.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(t,e){var n={},r=this,o="function"==typeof e;return i(h+"tracer",[f.now(),t,n],r),function(){if(c.emit((o?"":"no-")+"fn-start",[f.now(),r,o],n),o)try{return e.apply(this,arguments)}catch(t){throw c.emit("fn-err",[arguments,this,t],n),t}finally{c.emit("fn-end",[f.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){m[e]=o(h,e)}),newrelic.noticeError=function(t,e){"string"==typeof t&&(t=new Error(t)),u.recordSupportability("API/noticeError/called"),i("err",[t,f.now(),!1,e])}},{}],21:[function(t,e,n){function r(t){if(NREUM.init){for(var e=NREUM.init,n=t.split("."),r=0;r<n.length-1;r++)if(e=e[n[r]],"object"!=typeof e)return;return e=e[n[n.length-1]]}}e.exports={getConfiguration:r}},{}],22:[function(t,e,n){e.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(!("undefined"!=typeof FormData&&t instanceof FormData))try{return JSON.stringify(t).length}catch(e){return}}}},{}],23:[function(t,e,n){var r=!1;try{var o=Object.defineProperty({},"passive",{get:function(){r=!0}});window.addEventListener("testPassive",null,o),window.removeEventListener("testPassive",null,o)}catch(i){}e.exports=function(t){return r?{passive:!0,capture:!!t}:!!t}},{}],24:[function(t,e,n){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&&(r=+o[1]),e.exports=r},{}],25:[function(t,e,n){function r(t,e){var n=[a,t,{name:t},e];return i("storeMetric",n,null,"api"),n}function o(t,e){var n=[s,t,{name:t},e];return i("storeEventMetrics",n,null,"api"),n}var i=t("handle"),a="sm",s="cm";e.exports={constants:{SUPPORTABILITY_METRIC:a,CUSTOM_METRIC:s},recordSupportability:r,recordCustom:o}},{}],26:[function(t,e,n){function r(){return s.exists&&performance.now?Math.round(performance.now()):(i=Math.max((new Date).getTime(),i))-a}function o(){return i}var i=(new Date).getTime(),a=i,s=t(33);e.exports=r,e.exports.offset=a,e.exports.getLastTimestamp=o},{}],27:[function(t,e,n){function r(t,e){var n=t.getEntries();n.forEach(function(t){"first-paint"===t.name?l("timing",["fp",Math.floor(t.startTime)]):"first-contentful-paint"===t.name&&l("timing",["fcp",Math.floor(t.startTime)])})}function o(t,e){var n=t.getEntries();if(n.length>0){var r=n[n.length-1];if(f&&f<r.startTime)return;var o=[r],i=a({});i&&o.push(i),l("lcp",o)}}function i(t){t.getEntries().forEach(function(t){t.hadRecentInput||l("cls",[t])})}function a(t){var e=navigator.connection||navigator.mozConnection||navigator.webkitConnection;if(e)return e.type&&(t["net-type"]=e.type),e.effectiveType&&(t["net-etype"]=e.effectiveType),e.rtt&&(t["net-rtt"]=e.rtt),e.downlink&&(t["net-dlink"]=e.downlink),t}function s(t){if(t instanceof w&&!y){var e=Math.round(t.timeStamp),n={type:t.type};a(n),e<=h.now()?n.fid=h.now()-e:e>h.offset&&e<=Date.now()?(e-=h.offset,n.fid=h.now()-e):e=h.now(),y=!0,l("timing",["fi",e,n])}}function c(t){"hidden"===t&&(f=h.now(),l("pageHide",[f]))}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var f,u,d,p,l=t("handle"),h=t("loader"),m=t(30),v=t(23),w=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){u=new PerformanceObserver(r);try{u.observe({entryTypes:["paint"]})}catch(g){}d=new PerformanceObserver(o);try{d.observe({entryTypes:["largest-contentful-paint"]})}catch(g){}p=new PerformanceObserver(i);try{p.observe({type:"layout-shift",buffered:!0})}catch(g){}}if("addEventListener"in document){var y=!1,x=["click","keydown","mousedown","pointerdown","touchstart"];x.forEach(function(t){document.addEventListener(t,s,v(!1))})}m(c)}},{}],28:[function(t,e,n){function r(){function t(){return e?15&e[n++]:16*Math.random()|0}var e=null,n=0,r=window.crypto||window.msCrypto;r&&r.getRandomValues&&(e=r.getRandomValues(new Uint8Array(31)));for(var o,i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx",a="",s=0;s<i.length;s++)o=i[s],"x"===o?a+=t().toString(16):"y"===o?(o=3&t()|8,a+=o.toString(16)):a+=o;return a}function o(){return a(16)}function i(){return a(32)}function a(t){function e(){return n?15&n[r++]:16*Math.random()|0}var n=null,r=0,o=window.crypto||window.msCrypto;o&&o.getRandomValues&&Uint8Array&&(n=o.getRandomValues(new Uint8Array(t)));for(var i=[],a=0;a<t;a++)i.push(e().toString(16));return i.join("")}e.exports={generateUuid:r,generateSpanId:o,generateTraceId:i}},{}],29:[function(t,e,n){function r(t,e){if(!o)return!1;if(t!==o)return!1;if(!e)return!0;if(!i)return!1;for(var n=i.split("."),r=e.split("."),a=0;a<r.length;a++)if(r[a]!==n[a])return!1;return!0}var o=null,i=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var s=navigator.userAgent,c=s.match(a);c&&s.indexOf("Chrome")===-1&&s.indexOf("Chromium")===-1&&(o="Safari",i=c[1])}e.exports={agent:o,version:i,match:r}},{}],30:[function(t,e,n){function r(t){function e(){t(s&&document[s]?document[s]:document[i]?"hidden":"visible")}"addEventListener"in document&&a&&document.addEventListener(a,e,o(!1))}var o=t(23);e.exports=r;var i,a,s;"undefined"!=typeof document.hidden?(i="hidden",a="visibilitychange",s="visibilityState"):"undefined"!=typeof document.msHidden?(i="msHidden",a="msvisibilitychange"):"undefined"!=typeof document.webkitHidden&&(i="webkitHidden",a="webkitvisibilitychange",s="webkitVisibilityState")},{}],31:[function(t,e,n){function r(t,e){var n=[],r="",i=0;for(r in t)o.call(t,r)&&(n[i]=e(r,t[r]),i+=1);return n}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],32:[function(t,e,n){function r(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(o<0?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=r},{}],33:[function(t,e,n){e.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(t,e,n){function r(){}function o(t){function e(t){return t&&t instanceof r?t:t?f(t,c,a):a()}function n(n,r,o,i,a){if(a!==!1&&(a=!0),!l.aborted||i){t&&a&&t(n,r,o);for(var s=e(o),c=m(n),f=c.length,u=0;u<f;u++)c[u].apply(s,r);var p=d[y[n]];return p&&p.push([x,n,r,s]),s}}function i(t,e){g[t]=m(t).concat(e)}function h(t,e){var n=g[t];if(n)for(var r=0;r<n.length;r++)n[r]===e&&n.splice(r,1)}function m(t){return g[t]||[]}function v(t){return p[t]=p[t]||o(n)}function w(t,e){l.aborted||u(t,function(t,n){e=e||"feature",y[n]=e,e in d||(d[e]=[])})}var g={},y={},x={on:i,addEventListener:i,removeEventListener:h,emit:n,get:v,listeners:m,context:e,buffer:w,abort:s,aborted:!1};return x}function i(t){return f(t,c,a)}function a(){return new r}function s(){(d.api||d.feature)&&(l.aborted=!0,d=l.backlog={})}var c="nr@context",f=t("gos"),u=t(31),d={},p={},l=e.exports=o();e.exports.getOrSetContext=i,l.backlog=d},{}],gos:[function(t,e,n){function r(t,e,n){if(o.call(t,e))return t[e];var r=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[e]=r,r}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],handle:[function(t,e,n){function r(t,e,n,r){o.buffer([t],r),o.emit(t,e,n)}var o=t("ee").get("handle");e.exports=r,r.ee=o},{}],id:[function(t,e,n){function r(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");e.exports=r},{}],loader:[function(t,e,n){function r(){if(!T++){var t=O.info=NREUM.info,e=m.getElementsByTagName("script")[0];if(setTimeout(f.abort,3e4),!(t&&t.licenseKey&&t.applicationID&&e))return f.abort();c(E,function(e,n){t[e]||(t[e]=n)});var n=a();s("mark",["onload",n+O.offset],null,"api"),s("timing",["load",n]);var r=m.createElement("script");0===t.agent.indexOf("http://")||0===t.agent.indexOf("https://")?r.src=t.agent:r.src=l+"://"+t.agent,e.parentNode.insertBefore(r,e)}}function o(){"complete"===m.readyState&&i()}function i(){s("mark",["domContent",a()+O.offset],null,"api")}var a=t(26),s=t("handle"),c=t(31),f=t("ee"),u=t(29),d=t(21),p=t(23),l=d.getConfiguration("ssl")===!1?"http":"https",h=window,m=h.document,v="addEventListener",w="attachEvent",g=h.XMLHttpRequest,y=g&&g.prototype,x=!1;NREUM.o={ST:setTimeout,SI:h.setImmediate,CT:clearTimeout,XHR:g,REQ:h.Request,EV:h.Event,PR:h.Promise,MO:h.MutationObserver};var b=""+location,E={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-spa-1216.min.js"},R=g&&y&&y[v]&&!/CriOS/.test(navigator.userAgent),O=e.exports={offset:a.getLastTimestamp(),now:a,origin:b,features:{},xhrWrappable:R,userAgent:u,disabled:x};if(!x){t(20),t(27),m[v]?(m[v]("DOMContentLoaded",i,p(!1)),h[v]("load",r,p(!1))):(m[w]("onreadystatechange",o),h[w]("onload",r)),s("mark",["firstbyte",a.getLastTimestamp()],null,"api");var T=0}},{}],"wrap-function":[function(t,e,n){function r(t,e){function n(e,n,r,c,f){function nrWrapper(){var i,a,u,p;try{a=this,i=d(arguments),u="function"==typeof r?r(i,a):r||{}}catch(l){o([l,"",[i,a,c],u],t)}s(n+"start",[i,a,c],u,f);try{return p=e.apply(a,i)}catch(h){throw s(n+"err",[i,a,h],u,f),h}finally{s(n+"end",[i,a,p],u,f)}}return a(e)?e:(n||(n=""),nrWrapper[p]=e,i(e,nrWrapper,t),nrWrapper)}function r(t,e,r,o,i){r||(r="");var s,c,f,u="-"===r.charAt(0);for(f=0;f<e.length;f++)c=e[f],s=t[c],a(s)||(t[c]=n(s,u?c+r:r,o,c,i))}function s(n,r,i,a){if(!h||e){var s=h;h=!0;try{t.emit(n,r,i,e,a)}catch(c){o([c,n,r,i],t)}h=s}}return t||(t=u),n.inPlace=r,n.flag=p,n}function o(t,e){e||(e=u);try{e.emit("internal-error",t)}catch(n){}}function i(t,e,n){if(Object.defineProperty&&Object.keys)try{var r=Object.keys(t);return r.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(i){o([i],n)}for(var a in t)l.call(t,a)&&(e[a]=t[a]);return e}function a(t){return!(t&&t instanceof Function&&t.apply&&!t[p])}function s(t,e){var n=e(t);return n[p]=t,i(t,n,u),n}function c(t,e,n){var r=t[e];t[e]=s(r,n)}function f(){for(var t=arguments.length,e=new Array(t),n=0;n<t;++n)e[n]=arguments[n];return e}var u=t("ee"),d=t(32),p="nr@original",l=Object.prototype.hasOwnProperty,h=!1;e.exports=r,e.exports.wrapFunction=s,e.exports.wrapInPlace=c,e.exports.argsToArray=f},{}]},{},["loader",2,17,5,3,4]);</script><meta charset="UTF-8"/><meta name="robots" content="index, follow"/><meta name="DC.Creator" content="Xiaoming Fu"/><meta name="DC.Creator" content="Zhiwei Peng"/><meta name="DC.Creator" content="Chi Zhang"/><meta name="DC.Creator" content="Yong Xia"/><meta name="DC.Creator" content="Jianbing Zhang"/><meta name="DC.Creator" content="Wei Luo"/><meta name="DC.Creator" content="L. Jay Guo"/><meta name="DC.Creator" content="Honglang Li"/><meta name="DC.Creator" content="YuHuang Wang"/><meta name="DC.Creator" content="Daoli Zhang"/><meta name="DC.title" content="Controlled synthesis of brightly fluorescent CH 3 NH 3 PbBr 3 perovskite nanocrystals employing Pb(C 17 H 33 COO) 2 as the sole lead source  "/><meta name="DC.publisher" content="Royal Society of Chemistry"/><meta name="DC.Date" content="2018/01/03"/><meta name="DC.Identifier" scheme="doi" content="10.1039/C7RA11832E"/><meta name="DC.Language" content="en"/><meta name="citation_title" content="Controlled synthesis of brightly fluorescent CH 3 NH 3 PbBr 3 perovskite nanocrystals employing Pb(C 17 H 33 COO) 2 as the sole lead source  "/><meta name="citation_author" content="Xiaoming Fu"/><meta name="citation_author" content="Zhiwei Peng"/><meta name="citation_author" content="Chi Zhang"/><meta name="citation_author" content="Yong Xia"/><meta name="citation_author" content="Jianbing Zhang"/><meta name="citation_author" content="Wei Luo"/><meta name="citation_author" content="L. Jay Guo"/><meta name="citation_author" content="Honglang Li"/><meta name="citation_author" content="YuHuang Wang"/><meta name="citation_author" content="Daoli Zhang"/><meta name="citation_online_date" content="2018/01/03"/><meta name="citation_date" content="2018"/><meta name="citation_journal_title" content="RSC Advances"/><meta name="citation_volume" content="8"/><meta name="citation_issue" content="2"/><meta name="citation_firstpage" content="1132"/><meta name="citation_lastpage" content="1139"/><meta name="citation_doi" content="10.1039/C7RA11832E"/><meta name="citation_pdf_url" content="https://pubs.rsc.org/en/content/articlepdf/2018/ra/c7ra11832e"/><meta name="citation_abstract_html_url" content="https://pubs.rsc.org/en/content/articlelanding/2018/ra/c7ra11832e"/><meta name="citation_fulltext_html_url" content="https://pubs.rsc.org/en/content/articlehtml/2018/ra/c7ra11832e"/><link rel="shortcut icon" href=""/><link type="text/css" rel="stylesheet" href="/content/stylesheets/rschtml2.css?ver=6_2_1"/><link href="https://www.rsc-cdn.org/oxygen/assets/webfonts/fonts.min.css" rel="stylesheet" type="text/css"/><link type="text/css" rel="stylesheet" href="/content/stylesheets/pubs-ui.min.css"/><meta name="viewport" content="width=device-width, initial-scale=1"/><script type="text/javascript" src="/content/scripts/JQueryPlugins.min.js"> </script><script type="text/javascript" src="/content/scripts/GetAnchorText.js"> </script><script type="text/javascript">
    
      $(function() {
      $("table.tgroup tfoot th").attr("colspan", "100");
      $("table.tgroup.rtable").each( function (idx, el) {
      var tw = $(this).width();
      $(this).parent().css("min-width", tw+"px");
      });

      });
      
    </script><!--6_2_1--></head><body class="oxy-ui pubs-ui ahtml-page"><!--Google Tag Manager (noscript)--><noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-56FZ7G" height="0" width="0" style="display:none;visibility:hidden"> </iframe></noscript><!--End Google Tag Manager (noscript)--><div class="viewport autopad"><div class="pnl pnl--drop autopad"><span id="top"/><div id="wrapper"><div class="left_head"><a class="simple" href="/"><img class="rsc-logo" border="0" src="/content/NewImages/royal-society-of-chemistry-logo.png" alt="Royal Society of Chemistry"/></a><br/><span class="btnContainer"><a class="btn btn--tiny btn--primary" target="_blank" title="Link to PDF version" href="/en/content/articlepdf/2018/ra/c7ra11832e">View PDF Version</a></span><span class="btnContainer"><a class="btn btn--tiny btn--nobg" title="Link to previous article (id:c7ra11923b)" href="/en/content/articlehtml/2018/ra/c7ra11923b" target="_BLANK">Previous Article</a></span><span class="btnContainer"><a class="btn btn--tiny btn--nobg" title="Link to next article (id:c7ra10112k)" href="/en/content/articlehtml/2018/ra/c7ra10112k" target="_BLANK">Next Article</a></span></div><div class="right_head"><div id="crossmark_container"><div id="crossmark-content"><a id="open-crossmark" href="#" data-target="crossmark"><img style="max-width:100px" id="crossmark-logo" src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_square.svg" alt="Check for updates"/></a><script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"> </script></div></div><br/><span class="oa"><img src="/content/newimages/open_access_blue.png" alt=""/> Open Access Article<br/><img src="/content/newimages/CCBY-NC.svg" alt=""/>
This Open Access Article is licensed under a <a rel="license" href="http://creativecommons.org/licenses/by-nc/3.0/">Creative Commons Attribution-Non Commercial 3.0 Unported Licence</a></span></div><div class="article_info"> DOI: <a target="_blank" title="Link to landing page via DOI" href="https://doi.org/10.1039/C7RA11832E">10.1039/C7RA11832E</a>
(Paper)
<span class="italic"><a title="Link to journal home page" href="https://doi.org/10.1039/2046-2069/2011">RSC Adv.</a></span>, 2018, <strong>8</strong>, 1132-1139</div><h1 id="sect217"><span class="title_heading">Controlled synthesis of brightly fluorescent CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> perovskite nanocrystals employing Pb(C<small><sub>17</sub></small>H<small><sub>33</sub></small>COO)<small><sub>2</sub></small> as the sole lead source<a title="Select to navigate to footnote" href="#fn1">†</a></span></h1><p class="header_text">
<span class="bold">Xiaoming Fu<a title="Select to navigate to footnote" href="#fn2">‡</a>

</span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Xiaoming Fu (orcid.org/0000-0001-8829-4207) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0001-8829-4207"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span><sup><span class="sup_ref italic">ac</span></sup>, 
<span class="bold">Zhiwei Peng<a title="Select to navigate to footnote" href="#fn2">‡</a></span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Zhiwei Peng (orcid.org/0000-0002-8278-2565) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0002-8278-2565"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span><sup><span class="sup_ref italic">b</span></sup>, 
<span class="bold">Chi Zhang</span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Chi Zhang (orcid.org/0000-0001-9388-675X) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0001-9388-675X"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span><sup><span class="sup_ref italic">a</span></sup>, 
<span class="bold">Yong Xia</span><sup><span class="sup_ref italic">a</span></sup>, 
<span class="bold">Jianbing Zhang</span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Jianbing Zhang (orcid.org/0000-0003-0642-3939) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0003-0642-3939"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span><sup><span class="sup_ref italic">a</span></sup>, 
<span class="bold">Wei Luo</span><sup><span class="sup_ref italic">ae</span></sup>, 
<span class="bold">L. Jay Guo</span><sup><span class="sup_ref italic">e</span></sup>, 
<span class="bold">Honglang Li</span>*<sup><span class="sup_ref italic">d</span></sup>, 
<span class="bold">YuHuang Wang</span>*<sup><span class="sup_ref italic">b</span></sup><span class="bold"> and </span>
<span class="bold">Daoli Zhang</span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Daoli Zhang (orcid.org/0000-0003-0646-1572) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0003-0646-1572"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span>*<sup><span class="sup_ref italic">ab</span></sup>
<br/><a id="affa"><sup><span class="sup_ref italic">a</span></sup></a><span class="italic">School of Optical and Electronic Information, Huazhong University of Science and Technology, 1037 Luoyu Road, Hongshan District, Wuhan City, Hubei Province 430074, P. R. China. E-mail: <a href="mailto:zhang_daoli@hust.edu.cn">zhang_daoli@hust.edu.cn</a></span>
<br/><a id="affb"><sup><span class="sup_ref italic">b</span></sup></a><span class="italic">Department of Chemistry and Biochemistry, University of Maryland, 8051 Regent Drive, College Park, MD 20742, USA. E-mail: <a href="mailto:yhw@umd.edu">yhw@umd.edu</a></span>
<br/><a id="affc"><sup><span class="sup_ref italic">c</span></sup></a><span class="italic">School of Physics, Communication and Electronics, Jiangxi Normal University, 99 Ziyang Avenues, Nanchang City, Jiangxi Province 330022, P. R. China</span>
<br/><a id="affd"><sup><span class="sup_ref italic">d</span></sup></a><span class="italic">Institute of Acoustics, Chinese Academy of Sciences, 21 North 4th Ring Road, Haidian District, Beijing 100190, P. R. China. E-mail: <a href="mailto:lhl@mail.ioa.ac.cn">lhl@mail.ioa.ac.cn</a></span>
<br/><a id="affe"><sup><span class="sup_ref italic">e</span></sup></a><span class="italic">Department of Electrical Engineering and Computer Science, University of Michigan, Ann Arbor, MI 48109, USA</span>
</p><div id="art-admin"><span class="italic bold">Received 
27th October 2017
</span><span class="bold italic">, Accepted 19th December 2017</span></div><p class="bold italic">First published on 3rd January 2018</p><hr/><div class="abstract"><h2>Abstract</h2><p>Organometal halide perovskite nanocrystals hold vast potential for application in photovoltaics, light emitting diodes, low-threshold lasers, and photodetectors due to their size-tunable bandgap energies and photoluminescence as well as excellent electron and hole mobilities. However, the synthesis of such nanocrystals typically suffers from poor structural stability in solution and the coexistence of lamellate nanocrystals (nanoplatelets) and spherical nanocrystals (nanoparticles). Here we show that the pure nanoparticle morphology of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanocrystals can be realized by employing lead oleate (Pb(C<small><sub>17</sub></small>H<small><sub>33</sub></small>COO)<small><sub>2</sub></small>) as the sole lead source and controlled using short- and long-chain mixed alkyl ammonium. These nanocrystals are monodispersed (2.2 ± 0.4 nm in diameter), highly fluorescent (with a quantum yield approaching 85%), and highly stable in the solution (for more than 30 days). Comparative studies reveal that the shape of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanocrystals is strongly dependent on the lead source, PbBr<small><sub>2</sub></small> and Pb(C<small><sub>17</sub></small>H<small><sub>33</sub></small>COO)<small><sub>2</sub></small>, and evolves as a function of the ratio of short- and long-chain alkyl ammoniums in the precursors. At an optimal short to long-chain alkyl ammonium ratio of 4<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>6, the growth of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoplatelets can be selectively suppressed with Pb(C<small><sub>17</sub></small>H<small><sub>33</sub></small>COO)<small><sub>2</sub></small> as the sole lead source, enhancing the overall photoluminescence quantum yield of the produced CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanocrystals. This work reveals important new insights for controlled synthesis of perovskite nanocrystals with pure crystal shape and significantly improved photoluminescence properties and stability.</p></div><hr/>
<h2 id="sect371"><span class="a_heading">Introduction</span></h2>
<span>Organolead halide perovskites (OHP) are intensively researched for photovoltaics because of their high light conversion efficiency,<a title="Select to navigate to reference" href="#cit1"><sup><span class="sup_ref">1,2</span></sup></a> optimal bandgap energy<a title="Select to navigate to reference" href="#cit3"><sup><span class="sup_ref">3,4</span></sup></a> and excellent electron and hole mobilities.<a title="Select to navigate to reference" href="#cit5"><sup><span class="sup_ref">5,6</span></sup></a> These compounds, possessing a general formula of APbX<small><sub>3</sub></small> crystal structure (A = organic ammonium cation and X = halide anion), have been applied to solar cells and led to a breakthrough performance in photovoltaic power conversion efficiencies from 3.1% (<a title="Select to navigate to references" href="#cit8">ref. 8</a>) in 2009 to a certified 22.7% now.<a title="Select to navigate to references" href="#cit9"><sup><span class="sup_ref">9</span></sup></a> In addition to solar energy harvesting, the size-tunable bandgap energies and photoluminescence (PL) from perovskite materials also evoke the exploration of their potential uses as emission materials by decreasing the particle size to nanocrystals (NCs). With nanoscaled size, OHP NCs have sharp excitonic features, which provide a synthetically tunable system for systematic investigations of the nature and dynamics of the excited states of OHP.<a title="Select to navigate to references" href="#cit10"><sup><span class="sup_ref">10</span></sup></a> In the 1990s, Papavassiliou <span class="italic">et al.</span> systematically investigated the structure, optical and other related properties of OHP NCs,<a title="Select to navigate to reference" href="#cit11"><sup><span class="sup_ref">11,12</span></sup></a> in which the high photoluminescence quantum yield (PLQY) and large exciton binding energy offered interesting opportunities for application in field-effect transistors (FET) and light emitting diodes (LEDs).<a title="Select to navigate to reference" href="#cit13"><sup><span class="sup_ref">13,14</span></sup></a></span>
<p class="otherpara">In 2014, OHP NCs captured the attention of researchers again when Schmidt <span class="italic">et al.</span><a title="Select to navigate to references" href="#cit15"><sup><span class="sup_ref">15</span></sup></a> synthesized 6 nm-sized CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> perovskite NCs <span class="italic">via</span> a simple solution process. In their experiments, lead bromide (PbBr<small><sub>2</sub></small>), methylammonium bromide (MABr) and octylammonium bromide (OABr) were added to a stirring solution of oleic acid (OLA) and 1-octadecene (ODE) at 80 °C and the reaction was quenched by injecting acetone quickly. It is believed that the long alkyl chain cations acted as the capping ligands of the NCs to restrict the growth of the CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> array extending in three dimensions. Subsequent research found that two-dimensional nanoplatelets of organolead bromide perovskites coexisted with nanoparticles in the synthesis.<a title="Select to navigate to references" href="#cit16"><sup><span class="sup_ref">16</span></sup></a> Later on, a large number of experiments based on the solution process were carried out and these OHP NCs with higher PLQY were applied to novel optical devices.<a title="Select to navigate to reference" href="#cit17"><sup><span class="sup_ref">17–20</span></sup></a> However, these OHP NCs are unstable in solution and the structures are heterogeneous,<a title="Select to navigate to references" href="#cit21"><sup><span class="sup_ref">21</span></sup></a> with different crystal shapes including nanoparticles and nanoplatelets coexisting as mixtures. Light emitting devices require phosphors with high PLQY and narrow-band emissions.<a title="Select to navigate to references" href="#cit22"><sup><span class="sup_ref">22</span></sup></a> The coexistence of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoplatelets and nanoparticles hampers applications in practical optical devices because they behave different PL emission peaks and PLQY. From a synthetic point of view, when using inorganic PbBr<small><sub>2</sub></small> as the lead precursor, CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoplatelets will form by intercalation of guest organic moieties between the Pb–Br–Pb layers of the crystalline PbBr<small><sub>2</sub></small> host,<a title="Select to navigate to references" href="#cit23"><sup><span class="sup_ref">23</span></sup></a> implying that the formation of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoplatelets would be suppressed if PbBr<small><sub>2</sub></small> is replaced by other precursors as lead sources.</p>
<p class="otherpara">In the present work, we developed a facile method to synthesize monodispersive and stable CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> perovskite NCs using lead oleate (Pb(C<small><sub>17</sub></small>H<small><sub>33</sub></small>COO)<small><sub>2</sub></small>, Pb-oleate) as the sole lead source and ligand to replace PbBr<small><sub>2</sub></small> and OLA in the precursors. The resulting CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs showed pure and monodispersive nanoparticle structure with an average size of 2.2 nm, improved PLQY of 85%, and higher stability than those employing PbBr<small><sub>2</sub></small> as lead source and OLA or Pb-oleate as ligand. Our investigation further revealed that the mole ratios of long- and short-chain alkyl ammonium halides (OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small>) in the precursors can significantly affect the crystalline structures of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs toward nanoparticles and nanoplatelets with different layers <span class="italic">via</span> the quantum confinement effect. At an optimal OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> ratio of 4<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>6 with Pb-oleate as the sole lead source, the growth of nanoplatelets was essentially suppressed, generating pure CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoparticles with enhanced optical properties. Comparative studies also verified that the nanoplatelet structure lowered the overall quantum yields of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs. To the best of our knowledge, this is the first report obtaining pure monodispersive CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoparticles with favourable stability and good dispensability using Pb-oleate as the sole lead source in the reactants, and the results shown here may pave the way for further application of OHP NCs in optoelectronic devices.</p>

<h2 id="sect441"><span class="a_heading">Experimental section</span></h2>
<h3 id="sect443"><span class="b_heading">Chemicals</span></h3>
<span>Lead(<span class="small_caps">II</span>) oxide (PbO, 99.9%, Alfa), lead(<span class="small_caps">II</span>) bromide (PbBr<small><sub>2</sub></small>, 99%, Aladdin), methylamine (CH<small><sub>3</sub></small>NH<small><sub>2</sub></small>, 33 wt% in absolute ethanol, Aladdin), hydrobromic acid (HBr, 48 wt% in water, Aladdin), <span class="italic">N</span>, <span class="italic">N</span>-dimethylformamide (DMF, anhydrous, 99.8%, Alfa), oleic acid (OLA, ≥99%, Sigma-Aldrich), 1-octadecene (ODE, &gt;90%, Sigma-Aldrich) and <span class="italic">n</span>-octylamine (OA, C<small><sub>8</sub></small>H<small><sub>17</sub></small>NH<small><sub>2</sub></small>, 99%, Aladdin). All the chemicals were used as received without further purification.</span>

<h3 id="sect457"><span class="b_heading">Synthesis of alkylammonium bromide</span></h3>
<span>Alkylammonium bromide was synthesized by reaction between alkyl amine (CH<small><sub>3</sub></small>NH<small><sub>2</sub></small> or C<small><sub>8</sub></small>H<small><sub>17</sub></small>NH<small><sub>2</sub></small>) and HBr. Briefly, hydrobromic acid (5 mL, 44 mmol) was added to a solution of excess methylamine (12 mL, 96 mmol) in ethanol (50 mL) or slight less <span class="italic">n</span>-octylamine (7 mL, 42 mmol) at 0 °C. The mixture was continuously stirred for 4 h at 0 °C. Crystallization of alkylammonium bromide (MABr or OABr) was achieved using a rotary evaporator and washed three times with diethyl ether. The resulting powder was dried under vacuum (60 °C, 12 h) for future use.</span>

<h3 id="sect466"><span class="b_heading">Synthesis of Pb-oleate</span></h3>
<span>The reaction was performed on a Schlenk line using standard air-free techniques. In a typical synthesis, 3 mmol PbO, 7.5 mmol OLA and 30 mL ODE were mixed in a 150 mL flask, and then heated to 120 °C for 1 h under vacuum to obtain a clear solution, followed by natural cooling to the ambient temperature under N<small><sub>2</sub></small> blow protection. The solution was then quenched using acetone and the precipitates were redispersed in toluene to a concentration of 0.4 mol L<small><sup>−1</sup></small>.</span>

<h3 id="sect471"><span class="b_heading">Synthesis of hybrid CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs using PbBr<small><sub>2</sub></small> and Pb-oleate as lead sources</span></h3>
<span>Stock solutions of PbBr<small><sub>2</sub></small> and MABr, with the same concentration 0.5 mol L<small><sup>−1</sup></small>, were prepared in DMF. The solution of lead source was prepared by mixing the same mole of PbBr<small><sub>2</sub></small>–DMF and Pb-oleate–toluene solutions. The alkyl ammonium halides were prepared in DMF, and the molar ratios of OABr and MABr were tuned as 9<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1, 7<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>3, 6<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>4, 5<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>5, 4<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>6, 3<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>7, and 1<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>9. Then the reagents were mixed to obtain a series of precursor solutions with fixed total mole mass of PbBr<small><sub>2</sub></small> (4 mmol), alkyl ammonium bromides (4 mmol) and Pb-oleate (4 mmol). To obtain the desired perovskite crystallization, the precursor solution was added dropwise into 10 mL toluene under vigorous stirring at 80 °C. After centrifugation at 7000 rpm for 10 min to discard the precipitates, a bright yellow-green suspension or blue suspension was obtained because of different proportions of nanoplatelets and nanoparticles in solution. The solution of hybrid perovskite NCs was filtered using a polytetrafluoroethylene (PTFF) syringe filter (pore size 0.45 μm).</span>

<h3 id="sect482"><span class="b_heading">Synthesis of hybrid CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs using PbBr<small><sub>2</sub></small> and OLA</span></h3>
<span>Except for using OLA to replace Pb-oleate in the precursors, the synthesis scheme is similar to the synthesis of hybrid CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs using PbBr<small><sub>2</sub></small> and Pb-oleate as lead sources.</span>

<h3 id="sect493"><span class="b_heading">Synthesis of pure CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoparticles</span></h3>
<span>The precursor solution was prepared by mixing the Pb-oleate–toluene solution (4 mmol) and the alkyl ammonium bromides (4 mmol) with an OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> ratio of 4<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>6. To obtain the desired pure perovskite nanoparticles, the precursor solution was added into 10 mL toluene quickly under vigorous stirring at 80 °C. After centrifugation at 7000 rpm for 10 min to discard the precipitates, a bright green suspension was obtained, which was filtered using a polytetrafluoroethylene (PTFF) syringe filter (pore size 0.45 μm). Finally, there was nearly 100% chemical yield of the small CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> perovskite nanoparticles using Pb-oleate as sole lead source and an OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> ratio of 4<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>6.</span>
<p class="otherpara">It is noted that the above-mentioned synthesis of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoparticles can be scaled up. In addition, if only the two DMF solutions of PbBr<small><sub>2</sub></small> and MABr in 1<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1 ratio were employed in the absence of any ligands in the synthesis system and then dropped into 10 mL of anhydrous toluene under vigorous stirring, CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> would precipitate out as bulk crystals.</p>

<h3 id="sect514"><span class="b_heading">Characterization of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs</span></h3>
<span>The UV-vis absorption was recorded using UV-3600 plus of Shimadzu corporation and PL emission was collected in air using F-280 of Tianjin Gangdong Science &amp; Technology Co. Ltd. Relative quantum yield measurements were taken using a 0.5 mol L<small><sup>−1</sup></small> quinine sulphate as a reference and exciting at 336 nm. CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs samples in toluene were deposited on amorphous carbon-coated copper grids, and the morphology of the samples was investigated using an FEI Tecnai G2 20 or a JEM 2100 TEM operating at 200 kV for images of transmission electron microscopy (TEM). The solid colloidal NCs were obtained by fast evaporating the toluene on a hot plate at 80 °C. The X-ray diffraction (XRD) patterns were obtained on X'Pert PROX-ray diffractometer from PANalytical B.V. equipped with Cu K<small><sub>α</sub></small> radiation. The samples were scanned from 5° &lt; 2<span class="italic">θ</span> &lt; 50° in 5 min.</span>
<p class="otherpara">PLQY was calculated by the following formula:<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgugt1"><a href="/image/article/2018/RA/c7ra11832e/c7ra11832e-t1_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c7ra11832e-t1.tif" src="/image/article/2018/RA/c7ra11832e/c7ra11832e-t1.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td><a id="ugt1"/><span id="ugt1"/></td><td class="pushTitleLeft"> </td></tr></table></div>where <span class="italic">η</span><small><sub>P</sub></small> and <span class="italic">η</span><small><sub>Q</sub></small> represent PLQY of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs and quinine sulfate, while <span class="italic">S</span><small><sub>P</sub></small> and <span class="italic">S</span><small><sub>Q</sub></small> represent the photoluminescence integral area of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs and quinine sulfate, respectively.</p>


<h2 id="sect542"><span class="a_heading">Result and discussion</span></h2>
<span>To investigate the impact of lead sources and ligand on the structure of produced CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs, we used Pb-oleate, PbBr<small><sub>2</sub></small> + Pb-oleate, and PbBr<small><sub>2</sub></small> + OLA in the precursors with an fixed OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> ratio of 4<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>6, and the morphology of the synthesized CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs were first examined by TEM with an average diameter of 2.2 nm and a deviation of ±0.4 nm (<a title="Select to navigate to figure" href="#imgfig1">Fig. 1d</a>). High-resolution TEM image in <a title="Select to navigate to figure" href="#imgfig1">Fig. 1b</a> revealed that these nanoparticles are crystalline with a measured <span class="italic">d</span>-spacing of 2.6 Å. Together with the corresponding FFT pattern as shown in <a title="Select to navigate to figure" href="#imgfig1">Fig. 1c</a>, the exposing crystal facet was determined as (210). On the contrary, if PbBr<small><sub>2</sub></small> together with Pb-oleate was used as lead sources, the synthesized perovskite NCs showed a mixture of nanoparticles and nanoplatelets (<a title="Select to navigate to figure" href="#imgfig1">Fig. 1e</a>). When Pb-oleate was used as sole lead source and ligand in the reaction, the resulting perovskite NCs showed a monodispersed nanoparticle structure (<a title="Select to navigate to figure" href="#imgfig1">Fig. 1a</a>). Obviously, the use of inorganic lead source (PbBr<small><sub>2</sub></small>) promoted the growth of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs in the nanoplatelet formation with larger size than nanoparticles, possibly due to less amount of size-confining organo attachments at the crystal edges. As an additional control, PbBr<small><sub>2</sub></small> + OLA was also utilized as the lead source and ligand in the precursors, however the produced CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs presented a mixture of small-sized and large-sized cubic nanoparticles in addition with a thick organic cluster layers surrounding CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs. Additionally, the CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs synthesized from Pb-oleate were stable in toluene solution under ambient air conditions up to 30 days, but the ones from PbBr<small><sub>2</sub></small> + OLA or PbBr<small><sub>2</sub></small> + Pb-oleate gradually aggregated and precipitated out from the solution during the same period. The observed differences on the morphology and stability of the produced CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs suggests that (1) OLA as a ligand cannot effectively integrate with the CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs, and produces undesired organic impurities that embed the CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs; (2) the use of inorganic PbBr<small><sub>2</sub></small> as lead source results in the co-production of both nanoplatelets and nanoparticles; and (3) the use of Pb-oleate as both sole lead source and ligand can effectively restrain the growth of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoplatelets, producing pure CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoparticles with ultra-small sizes, narrow size distribution and higher stability. It is possible that during the formation of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs when using Pb-oleate as sole lead source, C<small><sub>17</sub></small>H<small><sub>33</sub></small>COO<small><sup>−</sup></small> ion from Pb-oleate was effectively coordinate at the surface of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs, confining the nanocrystal size and enhancing the stability of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs. When PbBr<small><sub>2</sub></small> was added into the reaction, guest organic moieties intercalated between the Pb–Br–Pb layers of the crystalline PbBr<small><sub>2</sub></small> host forming CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoplatelets.</span>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig1"><a href="/image/article/2018/RA/c7ra11832e/c7ra11832e-f1_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c7ra11832e-f1.tif" src="/image/article/2018/RA/c7ra11832e/c7ra11832e-f1.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 1 </b> <span id="fig1"><span class="graphic_title">Morphology of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs synthesized from different lead sources at OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> ratio of 4<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>6. (a) The TEM image of monodispersed CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoparticles synthesized from Pb-oleate as sole Pb source. (b) The HRTEM image of an individual, crystalline CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoparticle. (c) Corresponding FFT pattern of the HRTEM image in (b). (d) Size distribution of monodispersed CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoparticles. (e) TEM image of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs synthesized from Pb-oleate + PbBr<small><sub>2</sub></small> as Pb source. It shows a mixture of nanoplatelets and nanoparticles. (f) TEM image of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs synthesized from OLA + PbBr<small><sub>2</sub></small> as Pb source.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
<p class="otherpara">The structure and crystallinity of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs synthesized from three different precursors were further investigated with XRD (<a title="Select to navigate to figure" href="#imgfig2">Fig. 2</a>). Here, bulk CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> was also synthesized without the help of ligand and compared as reference. For the CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs synthesized from Pb-oleate + PbBr<small><sub>2</sub></small>, a series of diffraction peaks at 8.2°, 12.4°, 16.5°, 20.8°, 25.0°, 29.3°, and 33.7° were detected representing the layered diffractions of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoplatelets stacking in the sample.<a title="Select to navigate to references" href="#cit24"><sup><span class="sup_ref">24</span></sup></a> These diffraction peaks were at a regular interval of ∼4.2°, which corresponds to an average spacing of ∼2.1 nm between the layers in these nanoplatelets.<a title="Select to navigate to reference" href="#cit24"><sup><span class="sup_ref">24,25</span></sup></a> The observation of higher order peaks also testified that CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoplatelets are well crystallized. Due to much larger size of nanoplatelet than nanoparticles as revealed previous in the TEM image (<a title="Select to navigate to figure" href="#imgfig1">Fig. 1e</a>), the diffraction peaks from nanoplatelets in this sample were so dominating that any peaks from nanoparticles were almost negligible. With PbBr<small><sub>2</sub></small> + OLA as lead source and ligand, the series layered diffraction peaks of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoplatelets were absent while the diffraction peaks of bulk unit cell became preeminent, indicating that large-sized and crystalline CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoparticles were formed. When Pb-oleate was used both as sole lead source and ligand, the diffraction peak positions from the nanoparticles showed up and correlated well with the bulk CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> with a much broader peak width, verifying the nanoparticle structure with ultra-small size in the sample. Also, the absence of series layered diffraction peaks from nanoplatelets indicates the high purity of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs in the nanoparticle structure. A summary of XRD peaks and calculated <span class="italic">d</span>-space of the as-synthesized CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs from Pb-oleate and its comparison to bulk CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> is shown in Table S1.<a title="Select to navigate to footnote" href="#fn1">†</a></p>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig2"><a href="/image/article/2018/RA/c7ra11832e/c7ra11832e-f2_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c7ra11832e-f2.tif" src="/image/article/2018/RA/c7ra11832e/c7ra11832e-f2.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 2 </b> <span id="fig2"><span class="graphic_title">XRD patterns of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> bulk powders (black) and NCs synthesized from Pb-oleate (blue), Pb-oleate + PbBr<small><sub>2</sub></small> (red) and OLA + PbBr<small><sub>2</sub></small> (green) as lead source (● bulk unit cell, ♦ nanoplatelets stacks).</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
<p class="otherpara">With their distinct structure and morphology, these CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs synthesized from different precursors also presented different optical properties (<a title="Select to navigate to figure" href="#imgfig3">Fig. 3</a>). The CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs from OLA + PbBr<small><sub>2</sub></small> showed a dominated absorption peak at 396 nm and a small shoulder peak at 431 nm, corresponding to mono- and bi-layer CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoplatelets (<a title="Select to navigate to figure" href="#imgfig3">Fig. 3a</a>).<a title="Select to navigate to references" href="#cit11"><sup><span class="sup_ref">11</span></sup></a> When changing to Pb-oleate + PbBr<small><sub>2</sub></small>, the peak at 431 nm for bi-layer CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoplatelet became stronger, along with the appearance of an absorption peak from nanoparticles at around 520 nm as indicated by the orange arrow in <a title="Select to navigate to figure" href="#imgfig3">Fig. 3a</a>. Here, the higher absorption energy of nanoplatelets than nanoparticles is because of larger exciton binding energy.<a title="Select to navigate to reference" href="#cit11"><sup><span class="sup_ref">11,19,26</span></sup></a> As for Pb-oleate, the absorption peaks from nanoplatelets were disappeared, but the peak from nanoparticles remained, demonstrating again the pure nanoparticle morphology in this sample. PL emissions provide further evidence as shown in <a title="Select to navigate to figure" href="#imgfig3">Fig. 3b</a>. CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs from OLA + PbBr<small><sub>2</sub></small> presented only peaks at 442 and 476 nm representing bi- and four-layer CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoplatelets,<a title="Select to navigate to references" href="#cit11"><sup><span class="sup_ref">11</span></sup></a> while CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs from Pb-oleate + PbBr<small><sub>2</sub></small> showed both nanoplatelet peak at 434 nm and nanoparticle peak at 529 nm. As a comparison, the use of Pb-oleate as sole lead source resulted in only nanoparticle emission at 520 nm with no emissions from nanoplatelets. A picture of three solutions under UV 365 nm laser illumination was provided in <a title="Select to navigate to figure" href="#imgfig3">Fig. 3c</a>. The green colour in the samples synthesized from Pb-oleate and PbBr<small><sub>2</sub></small> + Pb-oleate clearly indicated the existence of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoparticles, in contrast with the one from PbBr<small><sub>2</sub></small> + OLA showing the blue colour. It is also worth noting that PLQY of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs from Pb-oleate as sole lead source were enhanced a factor of 2 and 4.3, respectively, compared to those from PbBr<small><sub>2</sub></small> + Pb-oleate and PbBr<small><sub>2</sub></small> + OLA, leading to an improved overall PLQY to 85% (<a title="Select to navigate to figure" href="#imgfig3">Fig. 3d</a>). Other than the type of lead sources, the amount of them also played an important role in determining the optical properties of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs. When changing the amount of Pb-oleate from 4 mmol, which is equivalent to the total amount of alkyl ammonium halides (OA<small><sup>+</sup></small> plus MA<small><sup>+</sup></small>), to less (2 mmol) or more (7 mmol), the absorption as well as PL emission from CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoparticles were significantly weakened (Fig. S1<a title="Select to navigate to footnote" href="#fn1">†</a>), indicating the lower quality of the produced perovskite NCs.</p>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig3"><a href="/image/article/2018/RA/c7ra11832e/c7ra11832e-f3_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c7ra11832e-f3.tif" src="/image/article/2018/RA/c7ra11832e/c7ra11832e-f3.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 3 </b> <span id="fig3"><span class="graphic_title">Optical properties of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs synthesized from different lead sources at OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> ratio of 4<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>6. (a) Absorption curves of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs synthesized from OLA + PbBr<small><sub>2</sub></small> (black), Pb-oleate + PbBr<small><sub>2</sub></small> (blue) and Pb-oleate (red) as lead source. The curves were offset for better comparison. (b) PL emission of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs synthesized from OLA + PbBr<small><sub>2</sub></small> (black), Pb-oleate + PbBr<small><sub>2</sub></small> (blue) and Pb-oleate (red) as lead source. The excitation wavelength was set at 350 nm. The curves were offset for better comparison. (c) Pictures of three CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs in toluene solutions taken under 365 nm laser illumination. (d) Quantum yield comparison of three CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs in toluene solutions.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
<p class="otherpara">To further investigate the growth mechanism of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs and control the morphology (nanoparticles or nanoplatelets), the ratios of long- and short-chain alkyl ammonium halides (OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small>) were varied (1<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>9, 3<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>7, 4<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>6, 5<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>5, 6<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>4, 7<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>3 and 9<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1) in the precursors with Pb-oleate as sole lead source. At the starting OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> ratio of 1<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>9, a strong absorption peak at 425 nm representing bi-layer CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoplatelets appeared while the absorption peak from CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoparticles at ∼520 nm was weak (<a title="Select to navigate to figure" href="#imgfig4">Fig. 4a</a>), indicating that the formation of nanoplatelets was dominated. With increasing percentage of OA<small><sup>+</sup></small> to 50% (OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> ratio of 5<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>5), the absorption peak of nanoplatelets quickly decreased to be negligible, and that of nanoparticles became noticeable, demonstrating the more favorable formation of nanoparticle structure. At increasing OA<small><sup>+</sup></small>, the absorption peak of nanoplatelets reappears along with the decrease of nanoparticle absorption. Similar trends were also observed in PL emission as shown in <a title="Select to navigate to figure" href="#imgfig4">Fig. 4b</a>, where the nanoplatelet PL peak at around 440 nm followed by a U-shape with varying OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> ratios from 1<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>9 to 9<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1. On the contrary, the nanoparticle PL (around 525 nm) peaks evolved in the opposite tendency, with lower intensity at larger OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> amount differences and higher intensity at even amount of OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small>. Interestingly, the overall PLQY of the solution followed the same tendency with nanoparticle PL intensity (<a title="Select to navigate to figure" href="#imgfig4">Fig. 4d</a>). Highest PLQY of 85% was achieved at an OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> ratio of 4<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>6 when PL peak intensity from nanoplatelets was the lowest and PL peak intensity from nanoparticles was the highest, again proving that the growth of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoplatelets needs to be suppressed in order to obtain the high PLQY. These PLQY values are consistent with previous reported on two-dimensional layered OHP NCs<a title="Select to navigate to references" href="#cit27"><sup><span class="sup_ref">27</span></sup></a> and monodisperse OHP nanoparticles<a title="Select to navigate to references" href="#cit28"><sup><span class="sup_ref">28</span></sup></a> obtained through different synthesis methods.</p>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig4"><a href="/image/article/2018/RA/c7ra11832e/c7ra11832e-f4_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c7ra11832e-f4.tif" src="/image/article/2018/RA/c7ra11832e/c7ra11832e-f4.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 4 </b> <span id="fig4"><span class="graphic_title">Investigation of the impact of OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> ratios on the optical properties of the resulting CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs solutions using Pb-oleate as sole lead source. (a) UV-vis absorption curves of as-made CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs solutions with varying OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> ratios. The curves were offset for better comparison. (b) PL emissions of as-made CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs solutions with varying OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> ratios. The excitation wavelength was set as 350 nm. (c) Picture of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs solutions synthesized from varying OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> ratios taken under UV light. The samples labeled from S1 to S7 represent different OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> ratios from 1<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>9 to 9<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1. (d) The overall PLQY of as-made CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs solutions and respective PL peak intensity of nanoplatelets and nanoparticles with varying OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> ratios.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
<p class="otherpara">The growth mechanism of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs can be revealed by the schematic overview in <a title="Select to navigate to scheme" href="#imgsch1">Scheme 1</a>. Generally speaking, during the growth of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs with both short-chain methylammonium (MA<small><sup>+</sup></small>) and long-chain octylammonium (OA<small><sup>+</sup></small>), the small MA<small><sup>+</sup></small> fits in the centre of eight PbBr<small><sub>6</sub></small> corner-shared octahedral, while the large OA<small><sup>+</sup></small> fits only the periphery of a set of four PbBr<small><sub>6</sub></small> octahedral in the formation of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs because of steric effects.<a title="Select to navigate to reference" href="#cit24"><sup><span class="sup_ref">24,29,30</span></sup></a> An interesting phenomenon aroused when a mixture of short and long organic cations was employed. While the small MA<small><sup>+</sup></small> entering the centre of PbBr<small><sub>6</sub></small> corner-shared octahedral tends to comfort the three-dimensional (3D) bulk perovskite structure, the long-chain cations (for example OA<small><sup>+</sup></small>) occupying the position of the small MA<small><sup>+</sup></small> makes the 3D perovskite structure unsuitable and thus it breaks up into smaller sized perovskite NCs. When using inorganic PbBr<small><sub>2</sub></small> as the lead precursor, CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs (including nanoparticles and nanoplatelets) will form by intercalation of the small MA<small><sup>+</sup></small> and large OA<small><sup>+</sup></small> between the Pb–Br–Pb layers of the crystalline PbBr<small><sub>2</sub></small> host (<a title="Select to navigate to scheme" href="#imgsch1">Scheme 1a</a>). However, using Pb-oleate as sole lead source, PbBr<small><sub>6</sub></small> corner-shared octahedral, provided bromide source by alkylammonium bromide, are formed firstly, and then are assembled to OHP NCs which are capped with the ligands of fatty acid (<a title="Select to navigate to scheme" href="#imgsch1">Scheme 1b</a>). If the ratios of long- and short-chain alkyl ammonium halides are suitable, the growth of nanoplatelets would be essentially suppressed, generating pure CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoparticles with enhanced optical properties.</p>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgsch1"><a href="/image/article/2018/RA/c7ra11832e/c7ra11832e-s1_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c7ra11832e-s1.tif" src="/image/article/2018/RA/c7ra11832e/c7ra11832e-s1.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Scheme 1 </b> <span id="sch1"><span class="graphic_title">Schematic overview of the grow mechanism of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs. (a) CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs (including nanoparticles and nanoplatelets) are both formed by intercalation of the small MA<small><sup>+</sup></small> and large OA<small><sup>+</sup></small> between the Pb–Br–Pb layers of the crystalline PbBr<small><sub>2</sub></small> host using inorganic PbBr<small><sub>2</sub></small> as the lead precursor. (b) Pure CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoparticles are obtained at an optimal OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> ratio of 4<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>6 with Pb-oleate as the sole lead source, suppressing the growth of nanoplatelets.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
<p class="otherpara">To further analyse the impact of OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> ratio on PL properties of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoparticles, the position and full width at half maximum (FWHM) of PL peaks of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoparticles were summarized in Fig. S2.<a title="Select to navigate to footnote" href="#fn1">†</a> We observed a blue shift of PL peak of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoparticles from 527 nm to 516 nm with increasing the ratio of OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small>, indicating a decreased nanoparticle size. This observation also proves the concept that the longer alkyl chain (OA<small><sup>+</sup></small>) restricts the 3D growth of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoparticles and thus strengthens the nano-size quantum confinement effect. At OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> ratios ranging from 3<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>7 to 7<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>3, FWHM was below 24 nm, showing narrow size distribution of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoparticles and in agreement with previous TEM imaging results (<a title="Select to navigate to figure" href="#imgfig1">Fig. 1</a>). The emission colours of different species under 365 nm laser illumination were illustrated in <a title="Select to navigate to figure" href="#imgfig4">Fig. 4c</a>. Considering all factors, the optimal growth conditions for monodispersed CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs were determined using Pb-oleate as sole lead source and an OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> ratio of 4<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>6, from which highly fluorescent CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoparticles could be synthesized as the potential phosphors in LEDs.</p>
<p class="otherpara">We further studied the impact of alkyl ammonium halides on the formation of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> perovskite NCs using PbBr<small><sub>2</sub></small> and Pb-oleate as lead sources. As shown in <a title="Select to navigate to figure" href="#imgfig5">Fig. 5a and b</a>, in general the absorption and emission peaks from nanoparticles at around 520 nm followed similar trends when using Pb-oleate as sole lead source in which the intensity increased first and then decreased along with increasing OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> ratios. This indicated that an even OA<small><sup>+</sup></small>/MA<small><sup>+</sup></small> amount would promote the growth of perovskite NCs in nanoparticle formation even with PbBr<small><sub>2</sub></small> as lead source. Although the exact position of absorption peak from nanoparticles was hard to be recognized, the blue-shifting effect was clearly observed as indicated by the red dashed arrow in <a title="Select to navigate to figure" href="#imgfig5">Fig. 5a</a>. Similarly, PL emission position of nanoparticles was blue-shifted from 528 nm at the OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> ratio of 1<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>9 to 507 nm at the OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> ratio of 9<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1 (<a title="Select to navigate to figure" href="#imgfig5">Fig. 5d</a>), again demonstrating the enhanced quantum confinement effect due to the increasing amount of long-chain OA<small><sup>+</sup></small>. As for the absorption from nanoplatelets, while the intensity of the peak at around 430 nm from bi-layer nanoplatelets followed a decreasing trend, a new peak at 396 nm originated from monolayer nanoplatelets started to appear at OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> ratio of 4<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>6 and continued to increase with increasing OA<small><sup>+</sup></small> amount (<a title="Select to navigate to figure" href="#imgfig5">Fig. 5c</a>). Apparently, when PbBr<small><sub>2</sub></small> was used as lead source, nanoplatelets were always formed with varying OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> ratios, and more OA<small><sup>+</sup></small> tended to promote the growth of nanoplatelets with fewer layers. This is in agreement with the assumption that long-chain ammonium halide will cause the size reduction of perovskite NCs. For mono- and bi-layer nanoplatelets, their absorption peak positions kept generally constant in each sample (<a title="Select to navigate to figure" href="#imgfig5">Fig. 5c</a>), which indicates the thickness of these nanoplatelets was essentially unchanged. Interestingly, even though the absorption intensity from monolayer nanoplatelets was in dominance at higher OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> ratios, its corresponding PL emission at 403 nm was almost absent in these samples. It reveals that the monolayer nanoplatelets contribute much less to the overall PLQY of perovskite NCs. Tyagi <span class="italic">et al.</span> observed similar phenomenon that the absorbed energy downhill transferred from the blue-emitting monolayer nanoplatelets to the red-emitting thicker nanoplatelets.<a title="Select to navigate to references" href="#cit16"><sup><span class="sup_ref">16</span></sup></a> Manser <span class="italic">et al.</span> suggested that the dominant relaxation pathway is recombination of free electrons and holes <span class="italic">via</span> femtosecond transient absorption spectroscopy measurements.<a title="Select to navigate to references" href="#cit31"><sup><span class="sup_ref">31</span></sup></a> The recombination of thinner nanoplatelets with its inherently high surface to volume ratio will be lower because of exceptional sensitivity to surface defects.<a title="Select to navigate to references" href="#cit31"><sup><span class="sup_ref">31</span></sup></a> Moreover, at an OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> ratio of 9<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1, multiple absorption and PL emission peaks can be resolved and assigned to different number of nanoplatelet layers from 1 to 5 (Fig. S3<a title="Select to navigate to footnote" href="#fn1">†</a>), which is in agreement with reported values from <a title="Select to navigate to references" href="#cit12">ref. 12</a> (<a title="Select to navigate to table" href="#tab1">Table 1</a>). The only absent emission peak of the tri-layer nanoplatelets may be due to interference by the adjacent strong peaks. The appearance of multiple PL emission peaks at higher OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> ratios indicates a weaker structure control of the grown perovskite NCs.</p>
<br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig5"><a href="/image/article/2018/RA/c7ra11832e/c7ra11832e-f5_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: c7ra11832e-f5.tif" src="/image/article/2018/RA/c7ra11832e/c7ra11832e-f5.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 5 </b> <span id="fig5"><span class="graphic_title">Investigation of the impact of OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> ratios on the optical properties of the resulting CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs solutions when using PbBr<small><sub>2</sub></small> + Pb-oleate as lead source. (a) UV-vis absorption curves of as-made CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs solutions with varying OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> ratios. The curves were offset for better comparison. (b) PL emissions of as-made CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs solutions with varying OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> ratios. The excitation wavelength was set as 350 nm. (c) The absorption peak intensity and position of mono- and bi-layer nanoplatelets from as-made CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs solutions with varying OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> ratios. (d) The PL peak intensity and position of nanoplatelets and nanoparticles from as-made CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs solutions with varying OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> ratios.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>

<div class="table_caption"><b>Table 1</b> <span id="tab1">Comparison of the absorption and PL peaks of 2D CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> nanoplatelets reported in <a title="Select to navigate to references" href="#cit12">ref. 12</a> and this work using Pb-oleate + PbBr<small><sub>2</sub></small> as lead source with OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> of 9<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>1</span>
		</div>

<div class="rtable__wrapper"><div class="rtable__inner"><table class="tgroup rtable" border="0"><colgroup><col/><col/><col/><col/><col/></colgroup>





<thead align="left">
<tr align="left" valign="bottom">
<th align="left" valign="bottom" class="border_black"><span class="italic">n</span><i><small><sup style="color: red;"><a title="" href="#tab1fna">a</a></sup></small></i></th>
<th align="left" valign="bottom" class="border_black">Abs (Ref) (nm)</th>
<th align="left" valign="bottom" class="border_black">Abs (Exp) (nm)</th>
<th align="left" valign="bottom" class="border_black">PL (Ref) (nm)</th>
<th align="left" valign="bottom" class="border_black">PL (Exp) (nm)</th>
</tr>
</thead>
<tfoot align="left">
<tr align="left">
<th colspan="5"><a id="tab1fna"><span class="tfootnote">a</span></a> <span class="sup_inf"><span class="italic">n</span> represents the number of layers of nanoplatelets. When <span class="italic">n</span> approaches to ∞, the corresponding structure changes to nanoparticle formation.</span></th>
</tr>
</tfoot>
<tbody align="left">
<tr align="left">
<td valign="top">1</td>
<td valign="top">396</td>
<td valign="top">396</td>
<td valign="top">405</td>
<td valign="top">403</td>
</tr>
<tr align="left">
<td valign="top">2</td>
<td valign="top">434</td>
<td valign="top">431</td>
<td valign="top">442</td>
<td valign="top">435</td>
</tr>
<tr align="left">
<td valign="top">3</td>
<td valign="top">450</td>
<td valign="top">448</td>
<td valign="top">456</td>
<td valign="top">—</td>
</tr>
<tr align="left">
<td valign="top">4</td>
<td valign="top">472</td>
<td valign="top">470</td>
<td valign="top">482</td>
<td valign="top">474</td>
</tr>
<tr align="left">
<td valign="top">5</td>
<td valign="top">490</td>
<td valign="top">485</td>
<td valign="top">492</td>
<td valign="top">489</td>
</tr>
<tr align="left">
<td valign="top">∞</td>
<td valign="top">532</td>
<td valign="top">—</td>
<td valign="top">534</td>
<td valign="top">508</td>
</tr>
</tbody>
</table></div></div>
<hr class="hrule"/><br/>

<h2 id="sect1048"><span class="a_heading">Conclusions</span></h2>
<span>We developed a new strategy for controllable synthesis of monodispersed and stable CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> perovskite NCs using Pb-oleate as sole lead source. A series of control experiments were designed and revealed that the mole ratios of long- and short-chain alkyl ammonium halides (OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small>) in the precursors have a significant impact on the crystal shape of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs. At an optimal OA<small><sup>+</sup></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>MA<small><sup>+</sup></small> ratio of 4<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>:<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>6, the growth of CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> NCs in the nanoplatelet shape is essentially suppressed, resulting in pure CH<small><sub>3</sub></small>NH<small><sub>3</sub></small>PbBr<small><sub>3</sub></small> perovskite nanoparticles with an average size of 2.2 nm and an improved photoluminescence quantum yield up to 85%. The result shown here provides important new insights for controlled synthesis of perovskite NCs with pure crystal shape and high quantum yield, paving the way for further applications of OHP NCs in optoelectronic devices.</span>

<h2 id="sect1067"><span class="a_heading">Conflicts of interest</span></h2>
<span>There are no conflicts of interest to declare.</span>


<h2 id="sect1071"><span class="a_heading">Acknowledgements</span></h2><span>Financial support from National Natural Science Foundation of China (Grant No. 51302096), China Scholarship Council (Grant No. 201606165006), the Fundamental Research Funds for the Central Universities (Grant No. 2015TS051), the Fundamental Research Funds of Wuhan City (Grant No. 2016060101010075), and the Innovation Foundation of Shenzhen Government (Grant No. JCYJ20160429182959405) are acknowledged. HLL acknowledges partial support from the National Key Research and Development Program of China (Grant No. 2016YFB0402705). YHW acknowledges partial support from AFOSR (Grant No. MURI FA9550-16-1-0150). The authors thank the Analytical and Testing Center of Huazhong University of Science and Technology and Maryland NanoCenter for making available the shared experimental facilities.</span>
<span id="sect1073"><h2 id="sect1070"><span class="a_heading">References</span></h2></span><ol type="1"><li><span id="cit1">W. J. Yin, T. Shi and Y. Yan, <span class="italic">Adv. Mater.</span>, 2014, <span class="bold">26</span>, 4653–4658 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201306281" title="DOI Link to resource 10.1002/adma.201306281">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXotVylsrw%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24827122%5Buid%5D" title="PubMed Link to resource 24827122">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c7ra11832e/1_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li><li><span id="cit2">S. De Wolf, J. Holovsky, S.-J. Moon, P. Löper, B. Niesen, M. Ledinsky, F.-J. Haug, J.-H. Yum and C. Ballif, <span class="italic">J. Phys. Chem. Lett.</span>, 2014, <span class="bold">5</span>, 1035–1039 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jz500279b" title="DOI Link to resource 10.1021/jz500279b">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXjsFOqsrs%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26270984%5Buid%5D" title="PubMed Link to resource 26270984">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c7ra11832e/2_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li><li><span id="cit3">H. Zhou, Q. Chen, G. Li, S. Luo, T. B. Song, H. S. Duan, Z. Hong, J. You, Y. Liu and Y. Yang, <span class="italic">Science</span>, 2014, <span class="bold">345</span>, 542–546 <a target="_blank" class="DOILink" href="https://doi.org/10.1126/science.1254050" title="DOI Link to resource 10.1126/science.1254050">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXht1aksrrO" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25082698%5Buid%5D" title="PubMed Link to resource 25082698">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c7ra11832e/3_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li><li><span id="cit4">V. D'Innocenzo, G. Grancini, M. J. Alcocer, A. R. S. Kandada, S. D. Stranks, M. M. Lee, G. Lanzani, H. J. Snaith and A. Petrozza, <span class="italic">Nat. Commun.</span>, 2014, <span class="bold">5</span>, 3586 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Nat.%20Commun.%5BJour%5D%20AND%205%5Bvolume%5D%20AND%203586%5Bpage%5D%20and%202014%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c7ra11832e/4_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li><li><span id="cit5">S. D. Stranks, G. E. Eperon, G. Grancini, C. Menelaou, M. J. Alcocer, T. Leijtens, L. M. Herz, A. Petrozza and H. J. Snaith, <span class="italic">Science</span>, 2013, <span class="bold">342</span>, 341–344 <a target="_blank" class="DOILink" href="https://doi.org/10.1126/science.1243982" title="DOI Link to resource 10.1126/science.1243982">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Wltr3K" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24136964%5Buid%5D" title="PubMed Link to resource 24136964">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c7ra11832e/5_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li><li><span id="cit6">G. Xing, N. Mathews, S. Sun, S. S. Lim, Y. M. Lam, M. Grätzel, S. Mhaisalkar and T. C. Sum, <span class="italic">Science</span>, 2013, <span class="bold">342</span>, 344–347 <a target="_blank" class="DOILink" href="https://doi.org/10.1126/science.1243167" title="DOI Link to resource 10.1126/science.1243167">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Wltr3F" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24136965%5Buid%5D" title="PubMed Link to resource 24136965">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c7ra11832e/6_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li><li><span id="cit7">A. Kojima, K. Teshima, Y. Shirai and T. Miyasaka, <span class="italic">J. Am. Chem. Soc.</span>, 2009, <span class="bold">131</span>, 6050–6051 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja809598r" title="DOI Link to resource 10.1021/ja809598r">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXksV2iurc%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19366264%5Buid%5D" title="PubMed Link to resource 19366264">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c7ra11832e/7_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li><li><span id="cit8">NREL, Best Research-Cell Efficiencies, http://https://www.nrel.gov/pv/assets/images/efficiency-chart.png, accessed 26 November 2017.</span></li><li><span id="cit9">Y. Hassan, Y. Song, R. D. Pensack, A. I. Abdelrahman, Y. Kobayashi, M. A. Winnik and G. D. Scholes, <span class="italic">Adv. Mater.</span>, 2016, <span class="bold">28</span>, 566–573 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201503461" title="DOI Link to resource 10.1002/adma.201503461">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXhvFens73E" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26596245%5Buid%5D" title="PubMed Link to resource 26596245">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c7ra11832e/9_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li><li><span id="cit10">G. C. Papavassiliou and I. Koutselas, <span class="italic">Synth. Met.</span>, 1995, <span class="bold">71</span>, 1713–1714 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/0379-6779(94)03017-Z" title="DOI Link to resource 10.1016/0379-6779(94)03017-Z">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaK2MXltlSqtb4%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c7ra11832e/10_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li><li><span id="cit11">G. C. Papavassiliou, <span class="italic">Prog. Solid State Chem.</span>, 1997, <span class="bold">25</span>, 125–270 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/S0079-6786(97)80886-2" title="DOI Link to resource 10.1016/S0079-6786(97)80886-2">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaK1cXhslWgsw%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c7ra11832e/11_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li><li><span id="cit12">C. Kagan, D. Mitzi and C. Dimitrakopoulos, <span class="italic">Science</span>, 1999, <span class="bold">286</span>, 945–947 <a target="_blank" class="DOILink" href="https://doi.org/10.1126/science.286.5441.945" title="DOI Link to resource 10.1126/science.286.5441.945">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaK1MXntFaktbw%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=10542146%5Buid%5D" title="PubMed Link to resource 10542146">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c7ra11832e/12_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li><li><span id="cit13">K. Chondroudis and D. B. Mitzi, <span class="italic">Chem. Mater.</span>, 1999, <span class="bold">11</span>, 3028–3030 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/cm990561t" title="DOI Link to resource 10.1021/cm990561t">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaK1MXmvVSmu7s%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c7ra11832e/13_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li><li><span id="cit14">L. C. Schmidt, A. Pertegás, S. González-Carrero, O. Malinkiewicz, S. Agouram, G. Minguez Espallargas, H. J. Bolink, R. E. Galian and J. Pérez-Prieto, <span class="italic">J. Am. Chem. Soc.</span>, 2014, <span class="bold">136</span>, 850–853 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja4109209" title="DOI Link to resource 10.1021/ja4109209">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXisFKksQ%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24387158%5Buid%5D" title="PubMed Link to resource 24387158">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c7ra11832e/14_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li><li><span id="cit15">P. Tyagi, S. M. Arveson and W. A. Tisdale, <span class="italic">J. Phys. Chem. Lett.</span>, 2015, <span class="bold">6</span>, 1911–1916 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.jpclett.5b00664" title="DOI Link to resource 10.1021/acs.jpclett.5b00664">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXnslGisbw%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26263268%5Buid%5D" title="PubMed Link to resource 26263268">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c7ra11832e/15_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li><li><span id="cit16">Y. Ling, Z. Yuan, Y. Tian, X. Wang, J. C. Wang, Y. Xin, K. Hanson, B. Ma and H. Gao, <span class="italic">Adv. Mater.</span>, 2016, <span class="bold">28</span>, 305–311 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201503954" title="DOI Link to resource 10.1002/adma.201503954">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXhvVeqtbrK" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26572239%5Buid%5D" title="PubMed Link to resource 26572239">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c7ra11832e/16_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li><li><span id="cit17">J. A. Sichert, Y. Tong, N. Mutz, M. Vollmer, S. Fischer, K. Z. Milowska, R. García Cortadella, B. Nickel, C. Cardenas-Daw and J. K. Stolarczyk, <span class="italic">Nano Lett.</span>, 2015, <span class="bold">15</span>, 6521–6527 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.nanolett.5b02985" title="DOI Link to resource 10.1021/acs.nanolett.5b02985">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXhsVeqsLbP" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26327242%5Buid%5D" title="PubMed Link to resource 26327242">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c7ra11832e/17_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li><li><span id="cit18">S. Pathak, N. Sakai, F. Wisnivesky Rocca Rivarola, S. D. Stranks, J. Liu, G. E. Eperon, C. Ducati, K. Wojciechowski, J. T. Griffiths and A. A. Haghighirad, <span class="italic">Chem. Mater.</span>, 2015, <span class="bold">27</span>, 8066–8075 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.chemmater.5b03769" title="DOI Link to resource 10.1021/acs.chemmater.5b03769">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXhslKlt7%252FN" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c7ra11832e/18_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li><li><span id="cit19">F. Zhang, H. Zhong, C. Chen, X.-g. Wu, X. Hu, H. Huang, J. Han, B. Zou and Y. Dong, <span class="italic">ACS Nano</span>, 2015, <span class="bold">9</span>, 4533–4542 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsnano.5b01154" title="DOI Link to resource 10.1021/acsnano.5b01154">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXlsFarsr0%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25824283%5Buid%5D" title="PubMed Link to resource 25824283">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c7ra11832e/19_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li><li><span id="cit20">S. Gonzalez-Carrero, R. E. Galian and J. Pérez-Prieto, <span class="italic">J. Mater. Chem. A</span>, 2015, <span class="bold">3</span>, 9187–9193 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXitVaqt7vF" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c7ra11832e/20_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li><li><span id="cit21">Y. Shirasaki, G. J. Supran, M. G. Bawendi and V. Bulović, <span class="italic">Nat. Photonics</span>, 2013, <span class="bold">7</span>, 13–23 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/nphoton.2012.328" title="DOI Link to resource 10.1038/nphoton.2012.328">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XhvV2ntLfI" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c7ra11832e/21_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li><li><span id="cit22">S. Ahmad, P. K. Kanaujia, W. Niu, J. J. Baumberg and G. Vijaya Prakash, <span class="italic">ACS Appl. Mater. Interfaces</span>, 2014, <span class="bold">6</span>, 10238–10247 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXptl2gtLg%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c7ra11832e/22_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li><li><span id="cit23">Y. Tabuchi, K. Asai, M. Rikukawa, K. Sanui and K. Ishigure, <span class="italic">J. Phys. Chem. Solids</span>, 2000, <span class="bold">61</span>, 837–845 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/S0022-3697(99)00402-3" title="DOI Link to resource 10.1016/S0022-3697(99)00402-3">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3cXjtV2qu7c%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c7ra11832e/23_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li><li><span id="cit24">M. C. Weidman, M. Seitz, S. D. Stranks and W. A. Tisdale, <span class="italic">ACS Nano</span>, 2016, <span class="bold">10</span>, 7830–7839 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsnano.6b03496" title="DOI Link to resource 10.1021/acsnano.6b03496">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28Xht1Kms7fO" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27471862%5Buid%5D" title="PubMed Link to resource 27471862">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c7ra11832e/24_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li><li><span id="cit25">G. C. Papavassiliou, G. Pagona, N. Karousis, G. A. Mousdis, I. Koutselas and A. Vassilakopoulou, <span class="italic">J. Mater. Chem.</span>, 2012, <span class="bold">22</span>, 8271–8280 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C2JM15783G&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C2JM15783G">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c7ra11832e/25_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li><li><span id="cit26">Z. Yuan, Y. Shu, Y. Xin and B. Ma, <span class="italic">Chem. Commun.</span>, 2016, <span class="bold">52</span>, 3887–3890 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C5CC09762B&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C5CC09762B">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c7ra11832e/26_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li><li><span id="cit27">H. Huang, F. Zhao, L. Liu, F. Zhang, X.-g. Wu, L. Shi, B. Zou, Q. Pei and H. Zhong, <span class="italic">ACS Appl. Mater. Interfaces</span>, 2015, <span class="bold">7</span>, 28128–28133 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXhvF2ltbrP" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c7ra11832e/27_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li><li><span id="cit28">D. H. Cao, C. C. Stoumpos, O. K. Farha, J. T. Hupp and M. G. Kanatzidis, <span class="italic">J. Am. Chem. Soc.</span>, 2015, <span class="bold">137</span>, 7843–7850 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jacs.5b03796" title="DOI Link to resource 10.1021/jacs.5b03796">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXptFWrtL8%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26020457%5Buid%5D" title="PubMed Link to resource 26020457">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c7ra11832e/28_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li><li><span id="cit29">S. Gonzalez-Carrero, G. M. Espallargas, R. E. Galian and J. Pérez-Prieto, <span class="italic">J. Mater. Chem. A</span>, 2015, <span class="bold">3</span>, 14039–14045 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXoslyrtrk%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c7ra11832e/29_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li><li><span id="cit30">J. S. Manser and P. V. Kamat, <span class="italic">Nat. Photonics</span>, 2014, <span class="bold">8</span>, 737–743 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/nphoton.2014.171" title="DOI Link to resource 10.1038/nphoton.2014.171">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXhtlahurvJ" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c7ra11832e/30_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li><li><span id="cit31">Y. Bekenstein, B. A. Koscher, S. W. Eaton, P. Yang and A. P. Alivisatos, <span class="italic">J. Am. Chem. Soc.</span>, 2015, <span class="bold">137</span>, 16008–16011 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jacs.5b11199" title="DOI Link to resource 10.1021/jacs.5b11199">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXitVSksr%252FF" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26669631%5Buid%5D" title="PubMed Link to resource 26669631">PubMed</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/c7ra11832e/31_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li></ol>




<hr/><table><tr><td><h3>Footnotes</h3></td></tr><tr><td><span class="sup_ref">† <span id="fn1">Electronic supplementary information (ESI) available. See DOI: <a href="http://xlink.rsc.org/?DOI=c7ra11832e" target="_blank" title="Select to resolve DOI: 10.1039/c7ra11832e">10.1039/c7ra11832e</a></span></span></td></tr><tr><td><span class="sup_ref">‡ <span id="fn2">These authors contribute equally to this work.</span></span></td></tr></table><table><tr><td><hr/></td></tr><tr><td><b>This journal is © The Royal Society of Chemistry 2018</b></td></tr></table></div></div></div></body><script src="/content/scripts/CrossMarkIE.js"> </script><SaxonLicenceTest result="pass" message="Licenced Enterprise Edition [ EE 9.3.0.4 ]"/></html>